Chemoinformaics analysis of Pseudosemiglabrinol
| Molecular Weight | 350.37 | nRot | 1 |
| Heavy Atom Molecular Weight | 332.226 | nRig | 26 |
| Exact Molecular Weight | 350.115 | nRing | 5 |
| Solubility: LogS | -4.565 | nHRing | 3 |
| Solubility: LogP | 3.903 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 51.0823 |
| nHD | 1 | BPOL | 24.1337 |
| QED | 0.728 |
| Synth | 3.762 |
| Natural Product Likeliness | 1.775 |
| NR-PPAR-gamma | 0.739 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.967 |
| Pgp-sub | 0.107 |
| HIA | 0.005 |
| CACO-2 | -4.758 |
| MDCK | 0.0000428 |
| BBB | 0.069 |
| PPB | 0.898179 |
| VDSS | 1.184 |
| FU | 0.0661049 |
| CYP1A2-inh | 0.361 |
| CYP1A2-sub | 0.176 |
| CYP2c19-inh | 0.197 |
| CYP2c19-sub | 0.16 |
| CYP2c9-inh | 0.506 |
| CYP2c9-sub | 0.569 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.439 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.187 |
| CL | 3.083 |
| T12 | 0.095 |
| hERG | 0.043 |
| Ames | 0.67 |
| ROA | 0.458 |
| SkinSen | 0.369 |
| Carcinogencity | 0.492 |
| EI | 0.103 |
| Respiratory | 0.948 |
| NR-Aromatase | 0.937 |
| Antiviral | Yes |
| Prediction | 0.898806 |